Upgrade to SI Premium - Free Trial

RBC Capital Upgrades ResMed (RMD) to Outperform

September 15, 2026 3:58 AM
RBC Capital analyst Craig Wong-Pan upgraded ResMed (NYSE: RMD) from Sector Perform to Outperform with a price target of $262.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Upgrades